Research Topics
| Meg WatsonSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
|
Detail Information
Publications
Burden of cervical cancer in the United States, 1998-2003Meg Watson
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Cancer 113:2855-64. 2008..This article provides a baseline for monitoring the impact of the HPV vaccine on the burden of cervical cancer over time...
Investment in safe routes to school projects: public health benefits for the larger communityMargaret Watson
Oak Ridge Institute for Science and Education Fellow, Division of Cancer Prevention and Control, CDC, 4770 Buford Highway, Mailstop K 55, Atlanta, GA 30341, USA
Prev Chronic Dis 5:A90. 2008..The Safe Routes to School (SRTS) program is designed to encourage active and safe transportation for children to school. This report examines the potential broader impact of these programs on communities within 0.5 mile (0.8 km) of schools...
Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methodsMeg Watson
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Cancer 113:2841-54. 2008....
Melanoma surveillance in the United States: overview of methodsMeg Watson
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
J Am Acad Dermatol 65:S6-16. 2011..Although recent reports suggest that melanoma incidence rates have been increasing, these apparent increases could be caused by an increase in reporting and/or screening, and by an actual increase in the occurrence of melanoma...
Update of HPV-associated female genital cancers in the United States, 1999-2004Meg Watson
Epidemiology and Applied Research Branch, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
J Womens Health (Larchmt) 18:1731-8. 2009..Enhancing current cancer surveillance systems, combined with special studies to collect data on in situ or precancerous lesions of these cancers, will provide important information in determining the potential impact of the HPV vaccine...
Incidence of in situ and invasive vulvar cancer in the US, 1998-2003Mona Saraiya
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
Cancer 113:2865-72. 2008..To provide a baseline picture before HPV vaccine implementation, the authors described vulvar cancer epidemiology by age, race, ethnicity, and histology in the US...
